The regulatory landscape for artificial intelligence (AI) is shaping up on both sides of the Atlantic, urgently awaited by the scientific and industrial community. Commonalities and differences start to crystallize in the approaches to AI in medicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Hierarchical AI enables global interpretation of culture plates in the era of digital microbiology
Nature Communications Open Access 28 October 2023
-
Bibliometric analysis of the global scientific production on machine learning applied to different cancer types
Environmental Science and Pollution Research Open Access 11 August 2023
-
Lifelong nnU-Net: a framework for standardized medical continual learning
Scientific Reports Open Access 09 June 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan (FDA, 2021).
Executive Office of the President: Guidance for Regulation of Artificial Intelligence Applications (The White House, 2020).
Proposal for a Regulation Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) (European Commission, 2021).
Vokinger, K. N., Feuerriegel, S. & Kesselheim, A. S. Lancet Digit. Health 3, 337–338 (2021).
Oren, O., Gersh, B. J. & Bhatt, D. L. Lancet Digit. Health 2, 486–488 (2020).
Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) (FDA, 2019).
Lavizzo-Mourey, R. J., Besser, R. E. & Williams, D. R. NEJM 18, 1681–1684 (2021).
Canto, J. G., Rogers, W. & Goldberg, R. J. JAMA 8, 813–822 (2012).
Parikh, R. B., Teeple, S. & Navathe, A. S. JAMA 322, 2377 (2019).
Kausha, A., Altman, R. & Langlotz, C. JAMA 324, 1212 (2020).
Muehlematter, U. J., Daniore, P. & Vokinger, K. N. Lancet Digit. Health 3, 195–203 (2021).
Rajkomar, A. et al. NPJ Digital Med. 1, 18 (2018).
Toscano, F., O’Donnell, E. & Unruh, M. et al. Eur. J. Publ. Health 28, cky213.401 (2018).
Die elektronische Patientenakte (Bundesministerium für Gesundheit, accessed 13 June 2021); https://www.bundesgesundheitsministerium.de/elektronische-patientenakte.html
Acknowledgements
This study was partially funded by the Swiss National Science Foundation (SNSF).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vokinger, K.N., Gasser, U. Regulating AI in medicine in the United States and Europe. Nat Mach Intell 3, 738–739 (2021). https://doi.org/10.1038/s42256-021-00386-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42256-021-00386-z
This article is cited by
-
Hierarchical AI enables global interpretation of culture plates in the era of digital microbiology
Nature Communications (2023)
-
Lifelong nnU-Net: a framework for standardized medical continual learning
Scientific Reports (2023)
-
Bibliometric analysis of the global scientific production on machine learning applied to different cancer types
Environmental Science and Pollution Research (2023)
-
The US Algorithmic Accountability Act of 2022 vs. The EU Artificial Intelligence Act: what can they learn from each other?
Minds and Machines (2022)